Sort
40,608 grants matching “prostate cancer”
The use of chitosan for cancer vaccine delivery
$610,288John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Therapeutic implication of CD38 in CLL
$610,215Asher A Chanan-Khan · Mayo Clinic Jacksonville · R01 · FY2021 · CA
Therapeutic implication of CD38 in CLL
$610,215Asher A Chanan-Khan · Mayo Clinic Jacksonville · R01 · FY2020 · CA
Therapeutic implication of CD38 in CLL
$610,213Asher A Chanan-Khan · Mayo Clinic Jacksonville · R01 · FY2019 · CA
Novel ctDNA biomarker for androgen therapy in metastatic prostate cancer
$610,019Christopher A Maher · Washington University · R01 · FY2025 · CA
TARGETING FOXA1 METHYLATION IN CASTRATION-RESISTANT PROSTATE CANCER.
$610,000University Of Mass At Boston · · FY2021 · Defense Health Agency
Administration, Evaluation, and Planning Core
$609,973Philip W Kantoff · Dana-Farber Cancer Inst · P50 · FY2011 · CA
Genetic determinants of gene expression phenotypes in aggressive prostate cancer
$609,950Liang Wang · Medical College Of Wisconsin · R01 · FY2012 · CA
A Nested Case-Control Study of Prostate Carcinogenesis
$609,939Benjamin A. Rybicki · Henry Ford Health System · R01 · FY2007 · ES
Harms of Hepatocellular Carcinoma Screening in Patients with Cirrhosis
$609,853Amit Singal · Ut Southwestern Medical Center · R01 · FY2020 · CA
Phenotypic marker-guided development of selective antimetastasis therapeutic leads
$609,809Sui Huang · Northwestern University At Chicago · R01 · FY2024 · CA
Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer
$609,798Xiao-Ou Shu · Vanderbilt University Medical Center · R01 · FY2022 · CA
Biobehavioral Effects of Qigong for Prostate Cancer Survivors with Fatigue
$609,765Anita Y Kinney · Rbhs -Cancer Institute Of New Jersey · R01 · FY2020 · CA
Advanced PET/CT Imaging for Improving Clincail Trials
$609,615Paul E Kinahan · University Of Washington · U01 · FY2010 · CA
Supplemental Se and Vitamin E and Pulmonary Function
$609,585Cornell University Ithaca · R01 · FY2004 · HL
Hyperpolarized 13C MRSI Monitoring of Pyruvate Metabolism to Assess Drug Action
$609,543Russell O Pieper · University Of California, San Francisco · P01 · FY2017 · CA
HRQoL Values for Cancer Survivors: Enhancing PROMIS Measures for CER
$609,539Benjamin M Craig · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2012 · CA
Biological Functions of Chromosomal Proteins
$609,495Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Development of Enabling Technologies for Clinical Ultrahigh Field Body MRI
$609,481Gregory John Metzger · University Of Minnesota · R01 · FY2021 · EB
Tumor Immunology & Host Response
$609,342Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2012 · CA
Harnessing the CRL4 ubiquitin ligase for antagonizing colorectal carcinogenesis
$609,229Pengbo Zhou · Weill Medical Coll Of Cornell Univ · R01 · FY2018 · CA
Prostate cancer risk stratification via computational 3D pathology
$609,178Jonathan T.c. Liu · University Of Washington · R01 · FY2023 · CA
Detection of metastases in lymph nodes using quantitative ultrasound
$609,145Ernest Joseph Feleppa · Riverside Research Institute · R01 · FY2019 · CA
A novel flat-panel detector for advanced on-board radiation therapy imaging
$609,121Ross I. Berbeco · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Role of Selenium in Cancer and Health
$609,110Dolph Hatfield · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA